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RESUMEN
La cloroacetilación de 1-Aminocarboxamida 1 propor-
cionó la cloroacetilamina 2 la cual experimentó el cierre 
del anillo al ser sometida a reflujo con anhídrido acético 
para proporcionar el derivado clorometilpirimido 3. Este 
último compuesto experimenta reacciones de sustitución 
nucleofílica con varias aminas primarias y secundarias 
que, a través de la reacción de Mannich proporcionaron 
las imidazopirimidotienoisoquinolinas 5a-c. El compuesto 
1 reacciona con anhídrido ftálico en ácido acético y DMF 
para proporcionar phthalimido- e isoindolopymimidotieno-
tetrahidroisoquinolinas 6, 7 respectivamente. 
La reacción con dietilmalonato proporcionó el pirimidocar-
boxylato 8 que reacciona con hidrato de hidrazina para dar 
la carbohidrazida 9,  la cual reacciona con trietilorthofor-
mato en la síntesis de triazepinopirimido 10. La reacción 
de 1 con sulfuro de carbono en piridina proporcionó la piri-
midintiona 13 que después de doble reacción de Mannich 
proporciona el nuevo derivado tiadiazinopirimido 14. La 
reacción de la tetrahidroisoquinolintiona 15 con 2-chloro-
metilbenzimidazole y posterior ciclación de Thorpe-Zeigler 
proporcionó el aminobenzoimidazolilo 18 que demostró su 
versatilidad como material de partida para la síntesis de 
los nuevos derivados heterocíclicos 19-22.
Palabras clave: Imidazol, Triazepina, Tiadiazina, Pirimidi-
na, síntesis, reacciones
SUMMARY
Chloroacetylation of 1-Aminocarboxamide 1 afforded the 
chloroacetylamino 2 which underwent ring closure upon 
reflux with acetic anhydride to afford the chloromethyl-
pyrimido 3. The latter compounds underwent nucleophilic 
substitution reactions with various primary and second-
ary amines which underwent Mannich reaction to give the 
imidazopyrimidothienoisoquinolines 5a-c. Compound 1 
react with phthalic anhydride in acetic acid and DMF to 
afford phthalimido and isoindolopyrimido thienotetrahy-
droisoquinoline 6, 7 respectively.
Reaction with diethylmalonate afforded the pyrimidocar-
boxylate 8 which react with hydrazine hydrate to give the 
carbohydrazide 9 which react with triethyl orthoformate 
for synthesis of triazepinopyrimido 10. Reaction of 1 with 
carbon disulfide in pyridine afforded the pyrimidinethione 
13 which underwent double Mannich reaction to give the 
novel thiadiazinopyrimido compound 14. Reaction of   tet-
rahydroisoquinoline thione 15 with 2-chloromethylbenz-
imidazole followed by Thorpe-Zeigler cyclization to afford 
the aminobenzoimidazolyl 18 which proved its versatil-
ity as starting material for synthesis of novel heterocyclic 
compounds 19-22. 
Keywords: Imidazole, Triazepine, Thiadiazine, Pyrimidine, 
synthesis, reactions
RESUM
La cloracetilació de la 1-Aminocarboxamida 1 proporcio-
na la cloroacetilamina 2 la qual experimenta el tancament 
de l‘anell al ser sotmesa a reflux amb anhídrid acètic per 
proporcionar el derivat clorometilpirimido 3. Aquest últim 
derivat experimenta reaccions de substitució nucleofílica 
amb varies amines primàries i secundàries que, mitjançant 
la reacció de Mannich proporcionen les imidazopirimi-
dotienoisoquinolines 5a-c. El producte 1 reacciona amb 
anhídrid ftàlic en àcid acètic i DMF per proporcionar fta-
limido- i isoindolopimimido-tien-tetrahidroisoquinolines 6, 
7 respectivament. 
La reacció amb dietilmalonat proporcionà el pirimidocar-
boxylat 8 que reacciona amb hidrat de hidrazina per donar 
la carbohidrazida 9,  la qual reacciona amb trietilortofor-
mat en la síntesi de triazepinopirimido 10. La reacció d’1 
amb sulfur de carboni en piridina proporciona la pirimidin-
tiona 13 que després de doble reacció de Mannich propor-
ciona el nou derivat tiadiazinopirimido 14. La reacció de la 
tetrahidroisoquinolintiona 15 amb 2-clorometilbenzimida-
zol i subseqüent ciclació de Thorpe-Zeigler proporciona 
el aminobenzoimidazolil derivat 18 cosa que demostrà la 
seva versatilitat com material de partida per a la síntesi 
dels nous derivats heterocíclics 19-22.
Paraules clau: Imidazol, Triazepina, Tiadiazina, Pirimidina, 
síntesi, reaccions
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INTRODUCTION
The tetrahydroisoquinoline family of alkaloids includes 
potent cytotoxic agents that display a range of biological 
properties such as antitumor, antimicrobial, anti-inflamma-
tory and anti-leukemic activities 1,2. 
Tetrahydropyrimidothienoisoquinolines and tetrahydro-
pyrimidothienoquinolines are useful compounds as anti-
anaphylactics, anti-inflammatories, and bacteriophage in-
hibitors 3. Thienoquinolines are reported to exhibit a broad 
spectrum of biological effects. Some of them are useful as 
memory enhancers 4, antiallergics 5, anti-inflammatories, 
immuno regulators, analgesics and antipyritics 6. Others 
are known to possess a good antibacterial 7 and antiana-
phylactic activities 8. 
Also, Thienopyrimidines have long been the subject of 
chemical and biological research. The interest in these 
compounds is related to their broad range of biological ac-
tivity, which is displayed by representatives of all the pos-
sible structural combinations of the thiophene and pyrimi-
dine systems. Some thienopyrimidines display analgesic 9, 
antipyretic 10,11, anti-inflammatory 12-15, and anti-allergenic 
effects 16-18. These compounds have been studied as anti-
neoplastic agents 19 and for lowering the cholesterol level 
in the cardiovascular system 20,21. 
These findings have led us to continue our work on thi-
enopyrimidine derivatives 22. In continuation of our work, 
we reported new methods for preparation of thienotetra-
hydroisoquinolines and incorporating many heterocyclic 
rings fused to this moiety which were proved to have sig-
nificant antibacterial and antifungal activities 23-26. 
RESULTS AND DISCUSSION: 
Reaction of aminocarboxamide 1 with chloro acetylchlo-
ride in dioxan followed by treating with sodium carbon-
ate solution afforded the chloroacetylamino derivative 2, 
which underwent ring closure using acetic anhydride to 
afford the chloromethyl compound 3. The latter can be ob-
tained by heating compound 1 with excess chloro acetyl-
chloride on water bath followed by treatment with sodium 
carbonate solution. The structure of the produced com-
pound 3 was elucidated on the basis of 1H NMR spectra 
which revealed the disappearance of signals at d 6.80 ppm 
characteristic for NH2 group and appearance of signals at 
d 4.60 ppm characteristic for CH2 and at 10.70 ppm for 
NH and confirmed by mass spectrum (m/z) 390.19 (M+) 
which in agreement with the postulated structure. Chlo-
roacetyl derivative 3 underwent nucleophilic substitution 
reactions with various primary and secondary amines in 
refluxed ethanol to afford 10-arylaminomethyl derivatives 
4a-f. Treatment of compounds 4 a-c with formaldehyde 
under Mannish conditions afforded imidazopyrimido  de-




















































e: R1, R2= -O(CH2)4





  Synthesis of the imidazopyrimidothienotetrahydroisoquinoline derivatives 
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When compound 1 was allowed to react with phthalic an-
hydride in boiling acetic acid. The reaction stopped at the 
stage of formation of 3-phthalimido derivative 6, whereas 
in boiling DMF a deeper condensation occurs to give a de-
rivative of a new heterocyclic system namely 5-morpholin-
4-yl-1,2,3,4-tetrahydro-14-oxoisoindolo [1’’,2’’:2’,3’]pyrim-
ido[4’,5’:4,5]thieno[2,3-c]isoquinolin-8-one (7). Reaction of 
compound 1 with diethyl malonate in acetic acid afforded 
Schiff’s base followed by elimination of ethanol to give 
the S-ethoxycarbonylmethyl derivative 8 (Scheme 2).
Compound 8 reacts with hydrazine hydrate to give the cor-
responding carbohydrazide derivative 9 which was used 
as versatile starting material for the synthesis of other 
heterocyclic compounds. Thus, reaction of 9 with triethyl 
orthoformate in presence of acetic acid yielded the triaz-
epino derivative 10. While the reaction with acetyl acetone 
in ethanol gives dimethylpyrazolo derivative 11. Conden-
sation of compound 9 with aromatic aldehydes gives the 


























































































 Codensation reactions of tetrahydropyrimidothienoisoquinolinecarbohydrazide
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Reaction of compound 1 with carbondisulfide in pyridine 
by heating on water bath for 10 hours afforded the py-
rimidothione 13 which underwent cyclization under double 
Mannish conditions using formaldehyde and aniline to give 






















































































































                      SCHEME 5
Mechanism of double Mannish reaction 
The mechanism of double Mannish reaction to afford com-
pound 14 was suggested in the following scheme.
Stirring a solution of isoquinolinethione 15 in acetic acid 
with sodium nitrite solution afforded the dimerized com-
pound 16. Also, Alkylation of 15 with 2-chloromethyl 
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benzoimidazole in ethanol in presence of fused sodium 
acetate gave the S-benzoimidazolyl derivative 17, which 
underwent Thorpe-Ziegler cyclization by using ethanolic 
sodium ethoxide solution to give aminobenzimidazolyl tet-
rahydro thienoisoquinoline 18. Cyclization of compound 
17 was confirmed using spectral analysis. IR of compound 
17 revealed an absorption band at 2210 cm-1 for the CN 
group, which disappeared upon being cyclized into 18 and 
showing bands characteristic of the NH, NH2 groups at 
3450-3200 cm-1. 1H NMR spectra of 18 showed the disap-
pearance of signals characteristic for the SCH2 group in 
the starting material and appearance of new signals at d 
7.70 ppm corresponding to NH2 group (Scheme 6). 
Condensation of compound 18 with benzaldehyde in re-
fluxing ethanol afforded the corresponding Schiff’s base 
which underwent Michael addition to afford hexahydroben-
zimidazo derivative 19 which refluxing in n-butanol losses 
hydrogen molecule to afford the corresponding tetrahy-
drobenzoimidazo derivative 20. While reaction with triethyl 
orthoformate gave benzimidazopyrimidothienoisoquino-
line 21. The structure of compound 21 was established on 
the basis of spectral analysis. IR spectrum of compound 
21 revealed disappearance an absorption bands for the 
NH2 group. 
1H NMR spectrum of 21 showed singlet signal 
at 10.05 corresponding to CH pyrimidine. Compound 18 
was converted to the corresponding triazino derivative 22 









































































Synthesis of tetrahydrobenzimidazopyrimido and tetrahydrobenzimidazotriazinothienoisoquionline
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EXPERIMENTAL 
Materials and Instruments
All melting points are corrected and measured on a Fisher-
John apparatus. IR spectra were recorded (KBr) with a Per-
kin-Elmer 1430 Spectrophotometer. 1H NMR and 13CNMR 
spectra were obtained on a Varian EM-390 MHz (90 MHz) 
and Joel 400 MHz spectrometers in CDCl3, DMSO-d6 and 
CF3CO2D using Me4Si as internal standard, and chemical 
shifts are expressed as ppm. Mass spectra were measured 
on a Joel-JMS 600 spectrometer. Analytical data were ob-
tained on Elemental Analyze system GmbH-VarioEL V.3 
microanalyzer in the central lab of Assiut University; amino-
carboxamide 1 and tetrahydroisoquinolinethione 15 were 
obtained as reported procedure [23]. Numbering of carbon 






























































































































































































A solution of  aminocarboxamide 1 (1 g, 3 mmol) and chlo-
roacetyl chloride (0.4 mL, 3.5 mmol) in dioxane (30 mL) 
was heated on water bath for 2 hrs. The solid product 
which obtained by cooling and pouring on diluted sodium 
carbonate solution was filtered off, dried and recrystallized 
from ethanol to give white crystals in (81 %, 1.00 g) yield, 
m.p.: 250-252oC.
Anal. Calcd. for C18H21ClN4O3S (408.91): C; 52.87, H; 5.18, 
Cl; 8.67, N; 13.7, S; 7.84, Found: C; 53.05, H; 5.32, Cl; 
8.43, N; 13.54, S; 7.93%. IR ν: 3400, 3271 cm-1 (NH, NH2 
amides), 2950, 2860 cm-1 (CH aliphatic), 1664 cm-1 (C=O 
amide). 1H NMR (DMSO-d6) d (ppm): 1.80 (m, 4H, 2CH2), 
2.70 (m, 4H, 2CH2), 3.50 (4H, m, 2CH2), 3.80 (m, 4H, 2CH2), 





A mixture of 2 (4 g, 0.01 mol) in of acetic anhydride (20 
mL) was refluxed for 2 hrs. The solid product which was 
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formed on cooling filtered off, dried and recrystallized from 
dioxane to give white crystals in (78.5 %, 3 g) yield. 
Method B:
A mixture of of 1 (3.32 g, 0.01 mol) and chloro acetyl-
chloride (3 mL, 38 mmol) was heated on water bath for 
3 hrs, then poured into cold water (100 mL), neutralized 
with 10% sodium carbonate solution to just alkaline. The 
solid product was filtered off, dried and recrystallized from 
dioxane to give white crystals in (77%, 3.00 g) yield. m.p.: 
308-310oC. 
Anal. Calcd. for C18H19ClN4O2S (390.89): C; 55.31, H; 4.90, 
Cl; 9.07, N; 14.33, S; 8.20, Found: C; 55.52, H; 5.12, Cl; 
8.87, N; 14.10, S; 8.00%. IR ν: = 3450 (NH), 2950, 2850 
cm-1 (CH aliphatic), 1650 cm-1 (CO), 1600 cm-1 (C=N) cm-1. 
1H NMR (CDCl3) d (ppm): 1.82 (4H, m, 2 x CH2 cyclohex-
eno), 2.70 (4H, m, 2 x CH2 cyclohexeno), 3.20 (4H, m, 2 x 
CH2-N morpholine), 3.80 (4H, m, 2 x CH2O- morpholine), 
4.60 (2H, s, CH2Cl), 10.70 (1H, s, NH.; EI-MS: m/z (%) = 
393 (M+2, 14), 391 (M+, 25), 359 (13), 347 (4), 335 (24), 333 
(51), 304 (7), 256 (5), 207 (9), 186 (26), 128 (19), 115 (30), 
97 (47), 88 (53), 73 (41), 71 (25), 69 (72), 67 (28), 61 (76), 59 




A mixture of 3 (3.90 g, 0.01 mol), and aniline (2.00 mL, 0.02 
mol) was heated for 5 min, then ethanol (20 mL) was add-
ed. The mixture was refluxed for 2 hrs. The solid product 
which is formed on hot filtered off, dried and recrystallized 
from dioxane to give (71%, 3.2 g) as white crystals. m.p.: 
288-290oC.
Anal. Calcd. for C24H25N5O2S (447.56): C; 64.41, H; 5.63, 
N; 15.65, S; 7.10, Found: C; 64.20, H; 5.85, N; 15.80; S; 
7.30%. IR ν: 3400, 3350 cm-1 (2NH), 3050 cm-1 (CH aro-
matic), 2920, 2850 cm-1 (CH aliphatic), 1650 cm-1 (CO 
amide). 1H NMR (DMSO-d6, 400 MHz,) d (ppm): 1.70 (m, 
4H, 2 x CH2 cyclohexeno), 2.60 (m, 4H, 2 x CH2 cyclohex-
eno), 3.20 (m, 4H, 2 x CH2-N morpholine), 3.80 (m, 4H, 
2 x CH2-O morpholine), 4.30 (s, 2H, CH2NH), 5.90 (s, 1H, 
NH), 7.05-7.50 (m, 5H, ArH), 11.20 (s, 1H, NH pyrimidine); 
13C-NMR (DMSO-d6, 400 MHz) d (ppm): 22.15 (CH2, C1 cy-
clohexeno), 22.86 (CH2, C-6 cyclohexeno), 27.01 (CH2, C-2 
cyclohexeno), 28.24 (CH2, C-5 cyclohexeno), 50.35 (2CH2-
N morpholine C-14, C17), 52.43 (CH2NH), 66.78 (2CH2O 
morpholine C15, C16), 113.5 (2CH , C-20, C-24 aromatic), 
116.32 (CH2, C-4 cycloexeno), 117.24 (CH, C-22 aromat-
ic), 121.18 (C-8), 123.89 (C-3), 129.60 (2CH, C-21, C-23 
aromatic), 142.63 (C-10), 146.85 (C-11), 148.00 (CH, C-19 




A mixture of 3 (1 g, 2.5 mmol), of p-toluidine (0.3 g, 2.8 
mmol) in ethanol (20 mL) and few drops of triethylamine 
was refluxed for 4 hrs. The solid product which formed on 
hot was filtered off and recrystallized from dioxane to give 
white crystals in (74%, 0.87 g) yield. m.p. 260-262oC.
Anal. Calcd. for C25H27N5O2S (461.59): C; 65.05, H; 5.90, 
N; 15.17, S; 6.95, Found: C; 65.27, H; 6.15, N; 14.97, S; 
7.05%. IR ν: 3450, 3400 cm-1 (NH), 2920, 2820 cm-1 (CH 
aliphatic), 1660 cm-1(CO amide), 1600 cm-1 (C=N). 1H NMR 
(CDCl3) d (ppm): 1.80 (s, 3H, CH3 p-tolyl), 2.30 (m, 4H, 2 
x CH2 cyclohexeno), 2.65 (m, 4H, 2 x CH2 cyclohexeno), 
3.25 (m, 4H, 2 x CH2N-morpholine), 3.70 (m, 4H, 2 x CH2-N 
morpholine), 4.30 (s, 2H, CH2NH), 6.20 (s, 1H, NH p-tolyl), 




Obtained by the reaction of 3 with p-anisidine to give white 
crystals in (77%, 0.94 g) yield. m.p.: 238-240oC.
Anal. Calcd. for C25H27N5O3S (477.59): C; 62.87, H; 5.70, 
N; 14.66, S; 6.71, Found: C; 63.07, H; 5.93, N; 14.46, S; 
6.58%. IR ν: 3480, 3450 cm-1 (2NH), 2920, 2850 (CH ali-
phatic), 1655 (CO amide), 1620 (C=N). 1H NMR (CDCl3) d 
(ppm): 1.80 (m, 4H, 2CH2 cyclohexeno), 2.65 (m, 4H, 2 x 
CH2 cyclohexeno), 3.10 (m, 4H, 2 x CH2-N morpholine), 
3.60 (m, 4H, 2CH2-O morpholine), 3.80 (s, 3H, OCH3), 4.30 
(s, 2H, CH2NH), 6.20 (s, 1H, NH p-anisyl), 6.55-6.80 (2d, 




A solution of 3 (3.9 g, 0.01 mol) in ethanol (20 mL) and di-
ethyl amine (1.4 mL, 0.02 mol) was refluxed for 2 hrs, and 
then the mixture was allowed to cool. The solid product 
was filtered off, dried and recrystallized from ethanol to 
give green crystals in(75%, 0.82 g) yield. m.p. 260-262oC.
Anal. Calcd. for C22H29N5O2S (427.57): C;, 61.80, H; 6.84, 
N; 16.38, S; 7.50, Found: C; 62.02, H; 7.00, N; 16.52, S; 
7.35%. IR ν: 3450 cm-1 (NH), 2950, 2850 cm-1 (CH aliphat-
ic), 1650 cm-1 (CO). 1H NMR (CDCl3) d (ppm): 1.30 (t, 6H, 
J = 9 Hz, 2CH 3 diethyl amino), 1.70 (m, 4H, 2 x CH2 cyclo-
hexeno), 2.85 (m, 4H, 2 x CH2 cyclohexeno), 3.15 (m, 4H, 2 
x CH2N-morpholine), 3.60 (m, 4H, 2 x CH2O-morpholine), 
4.10 (s, 2H, CH2N), 4.60 (q, 4H, J = 7.5 Hz, 2 x CH2 diethyl 




Obtained by the reaction of 3 with morpholine. The prod-
uct was recrystallized from ethanol to give (72%, 0.81 g) as 
green crystals. m.p.: 316-318oC.
Anal. Calcd. for C22H27N5O3S (441.56): C; 59.84, H; 6.16, 
N; 15.86, S; 7.26, Found: C; 60.00, H; 6.34, N; 16.10, S; 
7.42%.  IR ν: 3470 cm-1 (NH pyrimidine), 2950, 2850 cm-1 
(CH aliphatic), 1640 cm-1 (C=O amide). 1H NMR (CDCl3) d 
(ppm): 1.60 (m, 4H, 2 x CH2 cyclohexeno), 1.75 (m, 4H, 2 x 
CH2 cyclohexeno), 2.15 (m, 4H, 2 x CH2N-morpholine C-5), 
2.50 (m, 4H, 2 x CH2O-morpholine C-5), 3.10 (m, 4H, 2 x 
CH2N-morpholine C-11), 3.60 (m, 4H, 2 x CH2O-morpho-
line C-11), 3.70 (s, 2H, CH2N), 11.30 (s, 1H, NH pyrimidine). 
10-Piperidin-1-ylmethyl-5-morpholin-4-yl-1,2,3,4-tet-
rahydropyrimido[4’,5’:4,5] thieno[2,3-c]isoquinoline (4f)
Obtained by the reaction of 3 with piperidine. The product 
was recrystallized from ethanol to afford green crystals in 
(79%, 0.89 g) yield. m.p.: 320-322oC.
Anal. Calcd. for C23H29N5O2S (439.58): C; 62.84, H; 6.65, 
N; 15.93, S; 7.29,  Found: C; 63.04, H; 6.86, N; 16.15, S; 
7.43%. IR ν: 3480 cm-1 (NH), 2920, 2850 cm-1 (CHaliphat-
ic), 1650 cm-1 (C=O amide). 1H NMR (CDCl3) d (ppm): 1.50 
(m, 6H, 3 x CH2  piperidine H3: H5), 1.80 (m, 4H, 2CH2 
cyclohexeno), 2.20 (m, 4H, 2 x CH2 piperidine H2, H-6), 
2.60 (m, 4H, 2 x CH2 cyclohexeno), 3.30 (m, 4H, 2 x CH2N-
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morpholine), 3.70 (m, 4H, 2 x CH2O-morpholine), 3.85 (s, 





A mixture of 4 a-c (1 g, 2.2 mmol) was dissolved in warm 
ethanol (20 mL) then  formaldehyde (2mL, 35%) was 
added drop wise with stirring for 15 min. then the mixture 
was heated  for 2 h. at 50-60oC. The solid product which 
is formed on hot was filtered off, dried and recrystallized 




Yield: (35%, 0.36 g); m.p.: 334-336oC.
 Anal. Calcd. for: C25H25N5O2S (459.57): C; 65.34, H; 5.48, 
N; 15.24, S; 6.98, Found: C; 65.54, H; 5.25, N; 15.44, S; 
7.21%. 1H NMR (CF3CO2D): d (ppm): 2.10 (m, 4H, 2CH2 
cyclohexeno), 2.95 (m, 4H, 2 x CH2 cyclohexeno), 3.95 (m, 
4H, 2 x CH2N-morpholine), 4.25 (m, 4H, 2 x CH2O-morpho-
line), 5.10, 6.05 (2s, 4H, 2 x CH2 imidazole), 7.00-7.50 (m, 
5H, ArH). IR ν: 3030 cm-1 (CH aromatic), 2920, 2820 cm-1 




Yield: (58%, 0.60 g); m.p.: 308-310oC.
Anal. Calcd. for: C26H27N5O2S (473.60) C; 65.94, H; 5.75, 
N; 14.79, S; 6.77, Found: C; 66.13, H; 5.55, N; 15.00, S; 
6.97%. IR ν: 2920, 2850 cm-1 (CH aliphatic), 1670 cm-1 
(CO amide). 
1H NMR (CF3CO2D) d (ppm): 1.70 (s, 3H, CH3 
p-tolyl) 2.05 (m, 4H, 2CH2 cyclohexeno), 3.10 (m, 4H, 2 
x CH2 cyclohexeno), 3.80 (m, 4H, 2 x CH2N-morpholine), 
4.30 ((m, 4H, 2 x CH2O-morpholine), 5.05, 6.10 (2s, 4H, 2 x 




Yield: (62%, 0.63 g); m.p.: 312-314oC.
Anal. Calcd. for: C26H27N5O3S (489.60): C; 63.78, H; 5.56, 
N; 14.30, S; 6.55, Found: C; 63.56, H; 5.73, N; 14.52, S; 
6.74%. IR ν: 2950, 2820 cm-1 (CH aliphatic), 1665 cm-1 
(CO). 1H NMR (CF3CO2D) d (ppm): 1.60 (s, 3H, CH3 p-an-
isyl), 2.00 (s, 4H, 2CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 
cyclohexeno), 3.50 (m, 4H, 2 x CH2N-morpholine), 4.10 (m, 
4, 2 x CH2O-morpholine), 5.20, 6.35 (2s, 4H, 2 x CH2 im-
dazole), 7.30-7.60 (m, 4H, ArH); 
1 - P h t h a l i m i d o - 5 - m o r p h o l i n - 4 - y l - 6 , 7 , 8 , 9 -
tetrahydrothieno[2,3-c] isoquinolin-2-carboxamide (6)
A mixture of 1 (1.60 g, 5 mmol) and phthalic anhydride 
(0.80 g, 5 mmol) in glacial acetic acid (20 mL) was refluxed 
for 3 hrs. The solid product which is formed on hot filtered 
off, dried and recrystallized from dioxane to give green 
crystals in (65%, 1.40 g) yield. m.p. 256-258oC. 
Anal. Calcd. for: C24H22N4O4S (462.53): C; 62.32, H; 4.79, 
N; 12.11, S; 6.93, Found: C; 62.50, H; 5.00, N; 11.93, S; 
7.11%. IR ν: 3250, 3180 cm-1 (NH2), 3050 cm
-1 (CH aromat-
ic), 2920, 2850 cm-1 (CH aliphatic) 1720, 1685 cm-1 (3CO); 
1H NMR (DMSO-d6) d (ppm): 1.90 (4H, m, 2 x CH2 cyclo-
hexeno), 2.70 (4H, m, 2 x CH2 cyclohexeno), 3.20 (4H, m, 2 
x CH2N-morpholine), 3.80 (4H, m, 2 x CH2O-morpholine), 
7.30 (2H, s, NH2), 7.60-8.10 (4H, m, ArH). 
5-Morphol in-4-y l -1 ,2 ,3 ,4-hexahydro iso indo-
lo[1’’,2’’:2’,3’]pyrimido[4’,5’:4,5] thieno[2,3-c]isoquino-
lin-8,14-dione (7)
A mixture of 1 (1.6 g, 5 mmol) and phthalic anhydride (0.80 
g, 5 mmol) in DMF (20 mL) was refluxed for 10 hrs. The 
solid product which is formed by cooling filtered off, dried 
and recrystallized from ethanol to give yellow crystals in 
(56%, 1.20 g) yield. m.p.: 180-182oC. 
Anal. Calcd. for: C24H20N4O3S (444.52): C; 64.85, H; 4.54, 
N; 12.60, S; 7.21, Found: C; 65.00, H; 4.32, N; 12.82, S; 
7.40%. IR ν: 3030 cm-1 (CH aromatic), 2950, 2856 cm-1 
(CH aliphatic), 1722, 1670 cm-1 (2CO). 1H NMR (CDCl3) d 
(ppm): 1.70 (m, 4H, 2 x CH2 cyclohexeno), 2.80 (m, 4H, 2 
x CH2 cyclohexeno), 3.20 (4H, m, 2 x CH2N-morpholine), 
3.90 (4H, m, 2 x CH2O-morpholine), 7.30 -8.10 (m, 4H, 
ArH),  EI-MS: m/z (%) = 444 (M+1, 8), 443 (M+, 100), 442 (M-
1, 17), 429 (41), 419 (23), 410 (57), 405 (24), 398 (56), 384 
(32), 373 (26), 360 (17), 342 (23), 332 (96), 311 (15), 275 
(34), 256 (23), 230 (18), 218 (10), 201 (11), 143 (12), 130 
(12), 104 (20), 55 (3). 
(5-Morpholin-4-yl-8-oxo-1,2,3,4,9-pentahydropyrimi-
do[4’,5’:4,5]thieno[2,3-c] isoquinolin-10-yl)acetic acid 
ethyl ester (8)
A mixture of 1 (0.5 g, 1.5 mmol) and diethyl malonate (1.0 
ml, 6 mmol) in acetic acid (5 mL) was heated under reflux 
for 1hr. The solid product was formed on hot was filtered 
off and recrystallized from dioxane to give yellow crystals 
in (68%, 0.44 g) yield. m.p.: 270-272oC. 
Anal. Calcd. for: C21H24N4O4S (428.51): C; 58.86, H; 5.65; 
N; 13.07, S; 7.48, Found: C; 59.09, H; 5.86, N; 12.84, S; 
7.70%. IR ν: 3450 cm-1 (NH), 2920, 2850 cm-1 (CH aliphat-
ic), 1740 cm-1 (CO ester), 1640 cm-1 (CO amide). 1H NMR 
(DMSO-d6, 400 MHz): d (ppm): 1.20 (t, 3H, J = 9 Hz, CH3 
ester), 1.85 (m, 4H, 2 x CH2 cyclohexeno), 2.72 (m, 4H, 2 
x CH2 cyclohexeno), 3.34 (m, 4H, 2 x CH2N-morpholine), 
3.65 (m, 4H, 2 x CH2O-morpholine), 3.84 (s, 2H, CH2CO), 
4.15 (q, 2H, J = 7.5 Hz, CH2 ester) 11.30 (s, 1H, NH pyrimi-
dine), 13C NMR (DMSO-d6, 400 MHz) d (ppm): 14.60 (CH3 
ester), 22.00 (CH2, C-1 cyclohexeno), 22.62 (CH2, C-6 cy-
clohexeno), 26.60 (CH2, C-2 cyclohexeno), 27.37 (CH2, C-5 
cyclohexeno), 40.45 (CH2CO), 50.29 (2CH2N-morpholine, 
C-14, C-17), 61.44 (CH2 ester), 66.66 (2CH2O-morpholine, 
C-15, C-16), 117.97 (C-4), 120.97 (C-8), 122.67 (C-3), 
143.32 (C-10), 146.70 (C-11), 152.90 (C-7), 153.03 (C-9), 
161.79 (CO amide), 168.45 (CO ester). EI-MS: m/z (%) = 
429 (M+1, 40), 428 (M+, 100), 427 (M-1, 19), 397 (36), 383 
(53), 371 (79), 355 (27), 343 (34), 325 (24), 311 (27), 297 
(42), 270 (35), 256 (17), 240 (13), 226 (19), 212 (12), 174 
(16), 128 (10), 103 (8), 86 (24), 68 (9), 57 (4). 
(5-Morpholin-4-yl-8-oxo-1,2,3,4,9-pentahydropyrimi-
do[4’,5’:4,5]thieno[2,3-c]iso quinolin-10-yl)-acetic acid 
hydrazide (9)
A sample of 8 (0.5 g, 1.2 mmol) and hydrazine hydrate (1 
mL, 85%) was fused for 3 min. then ethanol (20 mL) was 
added. The mixture was refluxed for 2 hrs. The solid prod-
uct, which formed on hot was filtered off and recrystallized 
from ethanol to give white crystals in (56%, 0.27 g). m.p. 
296-298oC.
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Anal. Calcd. for: C19H22N6O3S (414.49): C; 55.06, H; 5.35, 
N; 20.28, S; 7.74, Found: C; 55.25, H; 5.55, N; 20.15, S; 
7.94%. IR ν: 3350-3150 cm-1 (NH, NH2), 2920, 2850 cm
-1 
(CH aliphatic), 1660, 1640 cm-1 (2 CO amide). EI-MS: m/z 
(%) = 414 (M+, 34), 332 (19), 325 (31), 294 (66), 271 (28), 
256 (23), 207 (21), 183 (28), 154 (30), 140 (17), 109 (59), 93 




A mixture of 9 (0.4 g, 1 mmol), triethyl orthoformate (2 mL, 
13.5 mmol) and few drops of acetic acid was heated under 
reflux for 1 hr. The solid product was filtered off and recrys-
tallized from dioxane to give yellow crystals in (50%, 0.20 
g) yield. m.p. > 360oC. 
Anal. Calcd. for: C20H20N6O3S (424.48): C; 56.59, H; 4.75, 
N; 19.80, S; 7.55, Found: C; 57.10, H; 5.00, N; 19.63, S; 
7.72%. IR ν: 3120 cm-1 (NH), 2920, 2850 cm-1 (CH aliphat-
ic), 1670 cm-1 (CO amide).  1H NMR (DMSO-d6, 400 MHz) 
d (ppm): 1.85 (4H, m, 2 x CH2 cyclohexeno), 2.65 (m, 4H, 
2 x CH2 cyclohexeno), 3.30 (m, 4H, 2 x CH2N-morpholine), 
3.50 (m, 4H, 2 x CH2O-morpholine), 3.80 (s, 2H, triazepine 
H-14), 8.20 (s, 1H, triazepine H-15), 12.40 (s, 1H, NH tri-
azepine); 13C NMR (DMSO-d6, 400 MHz) d (ppm):  22.19 
(CH2, C-1 cyclohexeno), 22.40 (CH2, C-6 cyclo- hexeno), 
26.70 (CH2, C-2 cyclohexeno), 27.67 (CH2, C-5 cyclohex-
eno), 40.67 (CH2CO triazepine), 50.27 (2CH2N-morpholine, 
C-17, C-20), 66.67 (2CH2O-morpholine, C-18, C-19), 
116.78 (C-4), 120.62 (C-8), 122.64 (C-3), 145.98 (C-11), 
151.48 (C-7), 153.77 (C-9), 159.77 (CO pyrimidine), 161.86 
(CO triazepine). EI-MS: m/z (%) = 425 (M+1, 3), 424 (M+, 4), 
403 (10), 351 (87), 321 (26), 306 (22), 279 (8), 252 (7), 238 
(4), 225 (6), 169 (8), 140 (11), 127 (12), 108 (26), 90 (44), 79 
(70), 70 (81), 57 (100).
10-[2-(3,5-dimethylpyrazol-1-yl)-2-oxoethyl]-5-mor-
pholin-4-yl-1,2,3,4tetrahydro pyrimido [4’,5’:4,5]thieno 
[2,3-c]isoquinolin-8 (9H)-one (11)
A mixture of compound 9 (0.5 g, 1.2 mmol) and acetylac-
etone (0.5 mL, 5 mmol) was fused for 5 min. then absolute 
ethanol (20 mL) was added and reflux continued for ad-
ditional 2 hrs. The solid product formed on hot filtered off, 
dried and recrystalized from dioxane to give 0.39 g (67%) 
11 as yellow crystals. m.p. 246-248oC.
Anal. Calcd. for: C24H26N6O3S (478.58) C; 60.23, H; 5.48, 
N; 17.56, S; 6.70, Found: C; 60.46, H; 5.70, N; 17.35, S; 
6.87%. IR  ν: 3400 cm-1 (NH), 2940, 2860 cm-1 (CH aliphat-
ic), 1660, 1640 cm-1 (2CO). 1H NMR (DMSO-d6) d (ppm): 
1.80 (m, 4H, 2 x CH2 cyclohexeno), 2.60 (m, 4H, 2 x CH2 
cyclohexeno), 3.20 (m, 4H, 2 x CH2N-morpholine), 3.60 (m, 
4H, 2 x CH2O-morpholine), 2.50, 2.70 (2s, 6H, pyrazole 
2CH3), 4.00 (s, 2H, CH2), 6.50 (s, 1H, pyrazole H-4), 11.50 




A mixture of carbohydrazide compound 9 (0.5 g, 1.2 
mmol), benzaldehyde (0.5 mL, 5 mmol) in absolute ethanol 
(20 mL) in presence of catalytic amount of piperidine was 
refluxed for 2 hrs. The solid product formed on hot filtered 
off, dried and recrystallized from dioxane to give yellow 
crystals in (48%, 0.29 g) yield. m.p. 264-266oC.
Anal. Calcd. for C26H26N6O3S (502.60): C; 62.13, H; 5.21, 
N; 16.72, S; 6.38, Found: C; 62.35, H; 5.00, N; 16.88, S; 
6.55%. IR ν: 3450, 3250 cm-1 (2NH), 3050 cm-1 (CH aro-
matic), 2920, 2820 cm-1 (CH aliphatic) 1670, 1650 cm
-1 
(2CO). 1H NMR (DMSO-d6) d (ppm): 1.80 (m, 4H, 2 x CH2 
cyclohexeno), 2.50 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 
4H, 2 x CH2N-morpholine), 3.50 (m, 4H, 2 x CH2O-mor-
pholine), 3.80 (s, 2H, H-14), 7.30-7.60 (m, 5H, ArH), 7.90 





A mixture of 1 (0.66 g, 2 mmol) and carbon disulphide (2 
mL) was refluxed on water bath for 5 hrs. in presence of 
anhydrous pyridine (4 mL). The solid product which was 
formed on hot filtered off and recrystallized from ethanol to 
give white crystals in (67.5%, 0.5 g) yield. m.p. 338-340oC.
Anal. Calcd. for C17H18N4O2S2 (374.49): C; 54.53, H; 4.84, 
N; 14.96, S; 17.12, Found: C; 54.74, H; 4.68, N; 15.15, S; 
17.30%. IR ν: 3450, 3350 cm-1 (2NH), 2950, 2850 cm-1 (CH 
aliphatic), 1685 cm-1 (CONH), 1225 cm-1 (C=S). 1H NMR 
(DMSO-d6) d (ppm): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 
2.60 (m, 4H, 2 x CH2 cyclohexeno), 3.30 (m, 4H, 2 x CH2N-
morpholine), 3.60 (m, 4H, 2 x CH2O-morpholine), 7.50 (s, 




A mixture of 13 (0.5 g, 1 mmol), formaldehyde (2 mL) and 
aniline (0.2 mL, 2 mmol) in ethanol (20 mL) in presence of 
few drops of acetic acid was refluxed for 30 min.. The solid 
precipitate which is formed on hot filtered off, dried and re-
crystallized from dioxan in (59%, 0.39 g) yield. m.p.>360oC. 
Anal. Calcd. for C25H25N5O2S2 (491.64): C; 61.08, H; 5.13, 
N; 14.24, S; 13.04, Found: C; 61.30, H; 5.25, N; 14.05, S; 
13.20%. IR ν: 3030 cm-1 (CH aromatic), 2920, 2820 cm-1 
(CH aliphatic), 1660 cm-1 (CO). 1H NMR (DMSO-d6, 400 
MHz) d (ppm): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 
4H, 2 x CH2 cyclohexeno), 3.20   (m, 4H, 2 x CH2N-mor-
pholine), 3.60 (m, 4H, 2 x CH2O-morpholine), 5.45, 5.80 
(2s, 4H, thiadiazine H-14, H-15), 6.90-7.30 (m, 5H, ArH). 
13C NMR (DMSO- d6, 400 MHz) d (ppm):  21.91 (CH2, C-1 
cyclohexeno), 22.58 (CH2, C-6 cyclohexeno), 26.63 (CH2, 
C-2 cyclohexeno), 27.28 (CH2, C-5 cyclohexeno), 40.68 
(2CH2N-morpholine, C-22, C-25), 66.64 (2CH2O-mor-
pholine, C-23, C-24), 114.30 (2CH, C17, C-21 aromatic), 
116.70 (C-4), 119.97 (C-19 aromatic), 120.67 (C-8), 122.23 
(2CH, C-18, C-20 aromatic), 123.05 (C-3), 143.94 (C-10), 
146.88 (C-11), 151.46 (C-16), 155.67 (C-12), 151.90 (C-7), 
153.87 (C-9), 162.01 (CO pyrimidine). EI-MS: m/z (%) = 
492 (M+1, 68), 491 (M+, 100), 435 (29), 358 (37), 341 (13), 
329 (21), 300 (30), 245 (3), 187 (1), 118 (10), 105 (29), 95 
(11), 85 (10), 71 (14), 57 (18).
3,3’-Disulfanediylbis(1-morpholino-5,6,7,8-tetrahy-
droisoquinoline-4-carbonitrile) (16)
Sodium nitrite solution (0.7 g, 10%, 0.01 mol) was added 
drop wise to a solution of tetrahydroisoquinolinethione 15 
(1 g, 3.63 mmol) in glacial acetic acid (20 mL) for 5 min. at 
room temperature. The solid product which was formed 
filtered off, dried and recrystallized from ethanol to afford 
brown crystal in 89% yield. m.p. 192-194oC.
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Anal. Calcd. for: C28H32N6O2S2 (548.73): C; 61.29, H; 5.88, 
N; 15.32, S; 11.69, Found: C; 61.14, H; 6.00, N; 15.49, S; 
11.54%. IR ν: 2920, 2850 cm-1 (CH aliphatic), 2200 cm-1 
(CN), 1620 cm-1 (C=N). 1H NMR (CDCl3) d (ppm): 1.80 (m, 
8H, 4 x CH2 cyclohexeno), 2.50 (m, 4H, 2 x CH2 cyclohex-
eno), 2.80 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 8H, 4 




A mixture of 15  (4 g, 0.01 mol) and 2-chloromethylbenzo[d]
imidazole (1.66 g, 0.01 mol) in presence of fused sodium 
acetate (4.10 g, 0.05 mol) was refluxed in ethanol (30 mL) 
for 30 min. The solid product which formed on hot filtered 
off, dried and recrystallized from ethanol to afford white 
crystals in 47% yield. m.p.: 160-162oC.
Anal. Calcd. for C22H23N5OS (405.53): C; 65.16, H; 5.72, 
N; 17.27, S; 7.91, Found: C; 65.05, H; 5.86, N; 17.38, S; 
8.05%. IR ν: 3450 cm-1 (NH), 3050 cm-1 (CH aromatic), 
2920, 2820 cm-1 (CH aliphatic), 2210 cm-1 (CN), 1640 cm-1 
(C=N). 1H NMR (DMSO-d6) d (ppm): 1.65 (4H, m, 2 x CH2 
cyclohexeno), 2.70 (4H, m, 2 x CH2 cyclohexeno), 3.30 
(4H, m, 2 x CH2N-morpholine), 3.70 (m, 4H, 2 x CH2O-
morpholine), 4.70 (s, 2H, H-15), 7.10-7.60 (4H, m, ArH), 
12.50 (s, 1H, NH benzimidazole). 
1-Amino-2-(1H-benzimidazol-2-yl)-5-morpholin-4-yl-
6,7,8,9-tetrahydrothieno [2,3-c]isoquinoline (18)
A solution of compound 17 (0.7 g, 1.7 mmol) in absolute 
ethanol (20 mL) and few drops of sodium ethoxide solution 
(prepared from 0.5 gm of finely divided sodium metal dis-
solved in 20 mL absolute ethanol) was refluxed for 2 hrs. 
The solid product which formed after cooling was filtered 
off, dried and recrystallized from ethanol to afford yellow 
crystals in 71% yield. m.p. 278-280oC.
Anal. Calcd. () for C22H23N5OS (405.53): C; 65.16, H; 5.72, 
N; 17.27, S; 7.91, Found: C; 65.30, H; 5.83, N; 17.08, S; 
8.00%. IR ν: 3450, 3200, 3250 cm-1 (NH, NH2), 3050 cm
-1 
(CH aromatic), 2920, 2850 cm-1 (CH aliphatic), 1600 cm-1 
(C=N). 1H NMR (DMSO-d6, 400 MHz) d (ppm): 1.76 (m, 
4H, 2 x CH2 cyclohexeno), 2.83 (m,4H, 2 x CH2 cyclohex-
eno), 3.34 (m, 4H, 2 x CH2N-morpholine), 3.88 (m, 4H, 2 
x CH2O-morpholine), 7.08-7.43 (m, 4H, ArH), 7.64 (s, 2H, 
NH2), 11.66 (s, 1H, NH benzimidazole); 
13C-NMR (DMSO-
d6, 400 MHz): 22.53 (CH2, C1 cyclohexeno), 23.10 (CH2, 
C-6 cyclohexeno), 27.93 (CH2, C-2 cyclohexeno), 29.10 
(CH2, C-5 cyclohexeno), 49.38 (2CH2-N morpholine C-12, 
C15, 66.54 (2CH2O morpholine C13, C14), 115.52 (2CH 
, C-16, C-19 aromatic), 116.62 (CH2, C-4 cycloexeno), 
121.29 (2CH, C-17, C-18 aromatic), 121.18 (C-8), 123.23 
(C-3), 123.46 (C-NH2), 138.51 (C-22 imidazole), 143.25 (C-




Aminobenzoimidazolyl compound 18 (0.4 g, 1 mmol) and 
benzaldehyde (1 mL, 0.01 mol) was gently refluxed for 15 
min. then ethanol (20 mL) was added and reflux continued 
for additional 2 hrs. The solid product which formed on 
cold filtered off, dried and recrystallized from dioxane to 
give yellow needles in 75% yield. m.p. 310-312oC.
Anal. Calcd. for C29H27N5OS (493.64): C; 70.56, H; 5.51, 
N; 14.19, S; 6.50, Found: C; 70.77, H;5.63, N; 14.32, S; 
6.67%. IR ν: 3250 cm-1 (NH), 3050 cm-1 (CH aromatic), 
2920, 2850 cm-1 (CH aliphatic), 1630 cm-1 (C=N). 1H NMR 
(DMSO-d6) d (ppm): 1.90 (m, 4H,  2 x CH2 cyclohexeno), 
2.80 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2N-
morpholine), 3.80 (m, 4H, 2 x CH2O-morpholine), 7.10 (s, 





Compound 19 (0.49 g, 1 mmol) was refluxed in n-butanol 
for 3 hrs. The solid product which formed on hot was re-
crystallized from dioxane to give green crystals in 40% 
yield. m.p.>360oC.
Anal. Calcd. () for: C29H25N5OS (491.62): C; 70.85, H; 5.13, 
N; 14.25, S; 6.52, Found: C; 71.00, H; 4.98, N; 14.43, S; 
6.35%. IR ν: 3030 cm-1 (CH aromatic), 2920, 2860 cm-1 
(CH aliphatic), 1640 cm-1 (C=N).  1H NMR (DMSO-d6, 400 
MHz) d (ppm): 1.78 (m, 4H, 2 x CH2 cyclohexeno), 2.94 (m, 
4H, 2 x CH2 cyclohexeno), 3.37 (m, 4H, 2 x CH2N-mor-
pholine), 3.88 (m, 4H, 2 x CH2O-morpholine), 7.46-7.80 (m, 
9H, ArH); 13C-NMR (DMSO-d6, 400 MHz): 22.43 (CH2, C1 
cyclohexeno), 22.94 (CH2, C-6 cyclohexeno), 26.36 (CH2, 
C-2 cyclohexeno), 28.68 (CH2, C-5 cyclohexeno), 48.55 
(2CH2-N morpholine C-26, C-29), 66.30 (2CH2O morpho-
line C-27, C-28), 115.43 (2CH , C-16, C-19 benzimidazole), 
116.62 (CH2, C-4 cyclohexeno), 120.60 (C-8), 121.29 (2CH, 
C-17, C-18 benzimidazole), 122.82 (C-3), 127.60 (2CH, 
C-21, C-25 phenyl), 127.93 (CH, C-23 phenyl), 128.62 
(2CH, C-22, C-24 phenyl), 129.88 (C-20 phenyl), 141.32 
(C-13), 143.68 (C-10), 146.76 (C-11), 152.08 (C-7), 154.54 




A mixture of of aminobenzoimidazolyl compound 18 (0.4 g, 
1 mmol) and triethyl orthoformate (2 mL) was refluxed for 
1hr. The solid product which formed on hot was collected 
and recrystallized from dioxane to afford yellow crystals in 
63% yield. m.p. 280-282oC.
Anal. Calcd. (%) for: C23H21N5OS (415.52): C; 66.48, H; 
5.09, N; 16.85, S; 7.72, Found: C; 66.57, H; 4.95, N; 17.00, 
S; 7.88. IR ν: 3030 cm-1 (CH aromatic), 2920, 2850 cm-1 
(CH aliphatic), 1625 cm-1 (C=N). 1H NMR (CF3CO2D): d 
(ppm): 2.00 (m, 4H, 2 x CH2 cyclohexeno), 2.90 (m, 4H, 2 
x CH2 cyclohexeno), 3.90 (m, 4H, 2 x CH2N-morpholine), 
4.20 (m, 4H, 2 x CH2O-morpholine), 8.00-8.50 (m, 4H, 




Sodium nitrite (0.2 g, 4%) solution was added drop wise 
with stirring to a solution of benzimidazolyl compound 18 
(1 g, 2.5 mmol) in glacial acetic acid (10 mL) and HCl (1 
mL). Stirring was continued for 15 min. at room tempera-
ture. The solid precipitate which was formed by stirring 
was collected and recrystallized from acetic acid to give 
yellow crystals in 45% yield. m.p. 248-250oC.
Anal. Calcd. for: C22H20N6OS (416.51) C; 63.44, H; 4.84, 
N; 20.18, S; 7.70, Found: C; 63.29, H; 5.00, N; 20.34, S; 
7.58%. IR ν: 3050 cm-1 (CH aromatic), 2920, 2850 cm-1 (CH 
aliphatic), 1620 cm-1 (C=N). 1H NMR (CF3CO2D) d (ppm): 
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1.85 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 
cyclohexeno), 3.25 (m, 4H, 2 x CH2N-morpholine), 3.80 (m, 
4H, 2 x CH2O-morpholine), 7.50-8.30 (m, 4H, ArH). 
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